Announcements Trials

Browse Landscape

Phase

Status

Completed 13 Recruiting 5 Unknown 3 Withdrawn 1 Terminated 1 Suspended 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 82 Brain Neoplasms 79 Glioma 63 Neoplasms 16 Neuroblastoma 15 Meningioma 14 Medulloblastoma 13 Neurofibromatosis 1 10 Ependymoma 10 Meningeal Carcinomatosis 9 Carcinoma, Non-Small-Cell Lung 9 Breast Neoplasms 8 Neurologic Manifestations 6 Diffuse Intrinsic Pontine Glioma 6 Astrocytoma 6 Spinal Cord Neoplasms 5 Recurrence 5 Central Nervous System Neoplasms 5 Pheochromocytoma 4 Paraganglioma 4 Oligodendroglioma 4 Lung Neoplasms 4 Sarcoma 3 Rhabdoid Tumor 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Neuroma, Acoustic 3 Neurofibroma, Plexiform 3 Head and Neck Neoplasms 3 Ganglioneuroblastoma 3

Interventions

Levetiracetam 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Seizures × CNS × Clear all

NCT05897658 2024-10-23

LeviTaTe Pilot

Hamilton Health Sciences Corporation

Phase 3 Not yet recruiting

Brain Neoplasms, Seizures

Data powered by HemOnc (CC BY 4.0) Colophon ⚡